Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma
Clinical trial NCT02341209 · TERMINATED
Trial details
- NCT number
- NCT02341209
- Sponsor
- Rochester General Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2021-02-06
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.